BNIP3L and melanoma: A subpopulation with high HIF1α expression not only showed significantly higher expression of the canonical HIF1 target BNIP3L, but also of PD-L1 (CD274), as compared to a melanoma subpopulation with low HIF1α expression (Fig. 5D).